Rethinking depression. (cover story)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Wilson, Clare (AUTHOR)
  • Source:
    New Scientist. 1/21/2023, Vol. 257 Issue 3422, p38-41. 4p. 1 Color Photograph, 2 Cartoon or Caricatures.
  • Additional Information
    • Subject Terms:
    • Abstract:
      Intriguingly, some SSRIs and other antidepressant medicines seem to suppress inflammation. This would explain why medications and talking therapies often work best together: the antidepressants make the brain more neuroplastic, while the person learns more helpful thought patterns. His idea to test ketamine as an antidepressant came from work showing that other drugs that bind to the normal receptors for glutamate seemed to reduce low mood in animals. Depression is one of the biggest medical problems facing societies worldwide, treatments have long been controversial and here was research showing that Prozac and other common antidepressants are based on a defunct hypothesis about what causes the condition. [Extracted from the article]
    • Abstract:
      Copyright of New Scientist is the property of New Scientist Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)